Patient safety and risk management
Comparison to other compound dosing For context, the dosing requirements of 5-amino-1mq differ significantly from traditional peptides
The complex is eventually released from lysosomes and transported across the cell membrane bound to one of two proteins in the blood circulation: Haptocorrin, which is responsible for the transport of B 12 to the liver
Based on preclinical (animal and cellular) data only, inhibition of NNMT by 5-Amino-1MQ is theorised to: Raise intracellular NAD+ levels Activate SIRT1 and other sirtuins (proteins linked to metabolic regulation) Reduce fat cell (adipocyte) size and proliferation Improve insulin sensitivity These effects have been demonstrated in mouse models (Neelakantan et al., 2019), but robust human clinical trial data are currently absent
Without blood testing, you cant confirm oral supplements are effectively raising your B12 levels
Monoacylglycerol lipase: a novel potential therapeutic target and prognostic indicator for hepatocellular carcinoma